Reasons for coming to hospital after treatment for community-acquired pneumonia on a ambulatory basis

Canadian Respiratory Journal

Volumn 13, Issue 3, 2006, Pages 139-143

  Shariatzadeh, Mohammedreza ^a   Marrie, Thomas J ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Community acquired pneumonia; Reasons for consulting hospital

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFACLOR; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; LEVOFLOXACIN; TELITHROMYCIN;

ADOLESCENT; ADULT; ANAPHYLAXIS; ARTICLE; CANADA; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ERUPTION; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAUSEA; OUTCOME ASSESSMENT; OUTPATIENT CARE; PRIORITY JOURNAL; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT REFUSAL; VOMITING;

EID: 33744821880     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/759694     Document Type: Article

References (27)

1. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Ther 1998;20:820-37.
2. Wennberg JE, McPherson K, Caper P. Will payment based on diagnosis-related groups control hospital costs? N Engl J Med 1984;311:295-300.
3. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000;31:347-82.
4. Marrie TJ, Beecroft MD, Herman-Gnjidic Z. Resolution of symptoms in patients with community-acquired pneumonia treated on an ambulatory basis. J Infect 2004;49:302-9.
5. Malcolm C, Marrie TJ. Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting. Arch Intern Med 2003;163:797-802.
6. Minogue MF, Coley CM, Fine MJ, Marrie TJ, Kapoor WN, Singer DE. Patients hospitalized after initial outpatient treatment for community-acquired pneumonia. Ann Emerg Med 1998;31:376-80.
7. Rosón B, Carratala J, Dorca J, Casanova A, Manresa F, Gudiol F. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis 2001;33:158-65.
8. Jedlovsky V, Fleischman JK. Pneumocystis carinii pneumonia as the first presentation of HIV infection in patients older than fifty. AIDS Patient Care STDS 2000;14:247-9.
9. Morris A, Lundgren JD, Masur H, et al. Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 2004;10:1713-20.
10. Lévy M, Dromer F, Brion N, Leturdu F, Carbon C. Community-acquired pneumonia. Importance of initial noninvasive bacteriologic and radiographic investigations. Chest 1988;93:43-8.
11. Counsell SR, Tan JS, Dittus RS. Unsuspected pulmonary tuberculosis in a community teaching hospital. Arch Intern Med 1989;149:1274-8.
12. Sopena N, Sabria M, Pedro-Botet ML, et al. Prospective study of community-acquired pneumonia of bacterial etiology in adults. Eur J Clin Microbiol Infect Dis 1999;18:852-8.
13. Bochud PY, Moser F, Erard P, et al. Community-acquired pneumonia. A prospective outpatient study. Medicine (Baltimore) 2001;80:75-87.
14. Lim WS, Macfarlane JT, Boswell TC, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: Implications for management guidelines. Thorax 2001;56:296-301.
15. Alves dos Santos JW, Torres A, Michel GT, et al. Non-infectious and unusual infectious mimics of community-acquired pneumonia. Respir Med 2004;98:488-94.
16. Casey KR. Neoplastic mimics of pneumonia. Semin Respir Infect 1995;10:131-42.
17. Chang J, Han J, Kim DW, et al. Bronchiolitis obliterans organizing pneumonia: Chinicopathologic review of a series of 45 Korean patients including rapidly progressive form. J Korean Med Sci 2002;17:179-86.
18. Song J, Gorgan L, Corkey R, Kwa SL. An unusual case of bronchiolitis obliterans organizing pneumonia concomitant with bronchioloalveolar carcinoma. Respiration 2004;71:95-7.
19. Epler GR. Bronchiolitis obliterans organizing pneumonia. Arch Intern Med 2001;161:158-64.
20. King TE Jr. BOOP: An important cause of migratory pulmonary infiltrates? Eur Respir J 1995;8:193-5.
21. Gross TJ, Chavis AD, Lynch JP III. Noninfectious pulmonary diseases masquerading as community-acquired pneumonia. Clin Chest Med 1991;12:363-93.
22. Corley DE, Winterbauer RH. Collagen vascular diseases. Semin Respir Infect 1995;10:78-85.
23. Strange C, Highland KB. Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med 2004;25:549-59.
24. Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother 2001;45:1721-9.
25. Doern GV. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin Infect Dis 2001;15:33(Suppl 3):S187-S92.
26. Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 1999;341:233-9.
27. Gotfried MH. Appropriate outpatient macrolide use in community-acquired pneumonia. J Am Acad Nurse Pract 2004;16:146,148,150 (passim).